Stina Singel

Technik-/Wissenschafts-/F&E-Leiter bei ASCENDIS PHARMA A/S

Vermögen: 373 682 $ am 30.04.2024

50 Jahre

Health Technology

Consumer Services

Aktive Positionen von Stina Singel

Unternehmen	Position	Beginn	Ende
ASCENDIS PHARMA A/S	Technik-/Wissenschafts-/F&E-Leiter	01.05.2020	-

Unternehmen	Position	Beginn	Ende
NEKTAR THERAPEUTICS	Corporate Officer/Principal	01.04.2019	01.05.2020
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Technik-/Wissenschafts-/F&E-Leiter	01.03.2014	01.04.2019

University of California San Diego	Doctorate Degree
The Salk Institute for Biological Studies	Doctorate Degree
Harvard University	Undergraduate Degree

International

Vereinigte Staaten	6
Dänemark	2

Operativ

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	2
Corporate Officer/Principal	1

Sektoral

Health Technology	4
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
ASCENDIS PHARMA A/S	Health Technology
NEKTAR THERAPEUTICS	Health Technology

Private Unternehmen	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology

Private Unternehmen

Health Technology